Browsing by Titles

Showing results 1 to 6 of 6

  • Kang, Dae-Si
  • Koo, Ja Wook
  • 2025-05
  • Kang, Dae-Si. (2025-05). DYRK1A modulates fear memory formation via epigenetic modification. Molecular Brain, 18(1). doi: 10.1186/s13041-025-01216-8
  • BioMed Central
  • View : 19
  • Download : 0

Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD

  • Lee, Hyun-Ju
  • Hwang, Jeong-Woo
  • Kim, Jieun
  • Jo, A-Ran
  • Park, Jin-Hee
  • Jeong, Yoo Joo
  • Jang, Ji-Yeong
  • Kim, Su-Jeong
  • Song, Jeong-Heon
  • Hoe, Hyang-Sook
  • 2024-10
  • Lee, Hyun-Ju. (2024-10). Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD. Frontiers in Immunology, 15. doi: 10.3389/fimmu.2024.1421455
  • Frontiers Media
  • View : 195
  • Download : 24
  • Kim, J.
  • Kim, S.-J.
  • Jeong, H.-R.
  • Park, J.-H.
  • Moon, M.
  • Hoe, H.-S.
  • 2022-10
  • Kim, J. (2022-10). Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A. Frontiers in Immunology, 13. doi: 10.3389/fimmu.2022.903309
  • Frontiers Media S.A.
  • View : 239
  • Download : 0
  • Park, Jin-Hee
  • Hwang, Jeong-Woo
  • Lee, Hyun-ju
  • Jang, Geum Mi
  • Jeong, Yoo Joo
  • Cho, Joonho
  • Seo, Jinsoo
  • Hoe, Hyang-Sook
  • 2023-06
  • Park, Jin-Hee. (2023-06). Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β. Frontiers in Immunology, 14. doi: 10.3389/fimmu.2023.1150940
  • Frontiers Media
  • View : 255
  • Download : 24
  • Jinhee Park
  • 2023
  • Jinhee Park. (2023). Lomerizine regulates LPS-induced neuroinflammation and tau phosphorylation in vivo. doi: 10.22677/THESIS.200000687356
  • DGIST
  • View : 167
  • Download : 0
  • Lee, Hyun-ju
  • Woo, Hanwoong
  • Lee, Ha-Eun
  • Jeon, Hyongjun
  • Ryu, Ka-Young
  • Nam, Jin han
  • Jeon, Seong Gak
  • Park, HyunHee
  • Lee, Ji-Soo
  • Han, Kyung-Min
  • et al
  • 2020-11
  • Lee, Hyun-ju. (2020-11). The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation. doi: 10.1016/j.freeradbiomed.2020.08.030
  • Elsevier Inc.
  • View : 565
  • Download : 0
1